Farallon Capital Management: Stock Portfolio, Performance and Latest Trades
13F portfolio value
$21.7B
89 holdings at Q2 2026
Get an email when Farallon Capital Management files a new 13F report
Free, no account needed. Unsubscribe with one click.
Farallon Capital Management's portfolio
As of Q2 2026, filed August 14, 2026 · prices as of October 8, 2026
| Company | Share of portfolio | Average buy price | Return | Current price | Last quarter |
|---|---|---|---|---|---|
| 14.9% | $34.94 | +438% | $188.12 | Reduced −0.4% | |
Electronic Arts Inc.285512109 | 9.51% | $204.23 | — | — | Added +6.0% |
| 4.68% | $40.03 | +62.5% | $65.04 | Added +15% | |
| 4.56% | $20.91 | +569% | $139.91 | No change | |
Exelixis Inc.EXEL | 4.29% | $22.85 | +158% | $59.02 | Added +2.7% |
Liquidia Corp.LQDA | 3.90% | $17.60 | +59.2% | $28.02 | Reduced −3.4% |
Amazon.com Inc.AMZN | 3.67% | $207.70 | +22.3% | $254.06 | Reduced −38% |
| 3.63% | $75.96 | +31.8% | $100.12 | No change | |
Natera Inc.NTRA | 3.52% | $69.61 | +461% | $390.79 | Reduced −31% |
| 3.09% | $451.60 | −17.9% | $370.95 | Reduced −30% | |
| 3.08% | $484.70 | +34.5% | $651.98 | Added +19% | |
| 2.96% | $26.90 | +27.2% | $34.21 | Added +48% | |
| 2.68% | $331.14 | −16.3% | $277.12 | Reduced −45% | |
| 2.63% | $68.60 | −38.7% | $42.04 | Added +41% | |
Broadcom Inc.AVGO | 2.55% | $343.37 | +4.9% | $360.14 | Reduced −35% |
Microsoft Corp.MSFT | 2.43% | $355.62 | +47.0% | $522.61 | Reduced −53% |
| 2.25% | $9.92 | +128% | $22.57 | Added +35% | |
| 2.21% | $113.60 | −21.2% | $89.56 | Reduced −12% | |
Synopsys Inc.SNPS | 2.17% | $445.61 | +11.7% | $497.75 | Reduced −32% |
| 2.06% | $39.95 | −38.4% | $24.60 | Added +1.0% | |
Crinetics Pharmaceuticals In22663K107 | 1.97% | $44.54 | — | — | Added +7.8% |
Grail Inc.GRAL | 1.66% | $56.93 | +133% | $132.61 | Added +28% |
Wabtec Corp.WAB | 1.41% | $146.34 | +91.9% | $280.80 | Reduced −44% |
Immunovant Inc.IMVT | 1.31% | $29.25 | +3.4% | $30.26 | Added +275% |
| 1.29% | $51.54 | +195% | $152.05 | Added +50% | |
| 1.29% | $28.88 | +10.5% | $31.92 | Added +4.1% | |
AramarkARMK | 1.21% | $33.85 | +64.1% | $55.54 | Reduced −41% |
| 0.81% | $120.83 | −30.5% | $83.92 | Added +171% | |
| 0.73% | $44.28 | −13.8% | $38.18 | Added +235% | |
| 0.73% | $22.56 | +26.2% | $28.48 | Added +143% | |
| 0.71% | $40.92 | +55.6% | $63.66 | Added +7.2% | |
| 0.64% | $189.95 | −16.4% | $158.78 | Added +153% | |
| 0.61% | $233.01 | +10.1% | $256.48 | Added +176% | |
Strategy Inc.Bond594972AS0 | 0.44% | — | — | — | Added +122% |
| 0.38% | $27.37 | +2.6% | $28.09 | New | |
| 0.33% | $149.91 | −4.5% | $143.11 | New | |
| 0.28% | $108.20 | +53.0% | $165.56 | Added +3928% | |
Vnet Group Inc.Bond90138AAE3 | 0.27% | — | — | — | No change |
| 0.27% | $15.74 | −14.7% | $13.43 | Added +173% | |
Joyy Inc-AdrJOYY | 0.27% | $47.94 | +68.6% | $80.85 | Added +21% |
| 0.26% | $23.18 | −1.6% | $22.82 | Added +31% | |
| 0.21% | $39.82 | −69.6% | $12.10 | Reduced −16% | |
| 0.19% | $32.24 | −19.7% | $25.88 | Added +197% | |
| 0.15% | $115.45 | +23.3% | $142.38 | Reduced −45% | |
| 0.15% | $24.76 | +0.8% | $24.95 | New | |
Freenome Inc.FRNM | 0.14% | $11.28 | +40.2% | $15.81 | No change |
| 0.14% | $21.98 | −54.5% | $10.00 | New | |
| 0.10% | $98.39 | −5.1% | $93.34 | Added +241% | |
| 0.10% | $30.08 | +9.1% | $32.81 | New | |
Abivax Sa-AdrABVX | 0.10% | $132.47 | −32.8% | $89.05 | Added +6000% |
Vnet Group Inc.VNET | 0.09% | $8.80 | −41.3% | $5.17 | Added +220% |
Netease Inc-AdrNTES | 0.09% | $124.07 | −3.6% | $119.60 | Reduced −58% |
Biogen Inc.BIIB | 0.09% | $191.29 | +14.2% | $218.43 | New |
| 0.09% | $5.92 | −25.1% | $4.43 | New | |
| 0.09% | $12.95 | −33.9% | $8.56 | New | |
Strategy Inc.Bond594972AN1 | 0.08% | — | — | — | New |
| 0.08% | $4.02 | −19.9% | $3.22 | No change | |
| 0.07% | $22.63 | +14.5% | $25.91 | New | |
Alvotech SAALVO | 0.06% | $4.13 | +37.1% | $5.67 | Added +1332% |
| 0.05% | $17.71 | −1.6% | $17.43 | Reduced −84% | |
Inflarx NVIFRX | 0.04% | $1.88 | −18.6% | $1.53 | New |
| 0.04% | $61.94 | −18.6% | $50.43 | New | |
| 0.03% | $21.03 | +25.9% | $26.48 | New | |
| 0.03% | $80.16 | −22.2% | $62.35 | New | |
Gentex Corp.GNTX | 0.03% | $23.65 | −10.6% | $21.15 | New |
| 0.03% | $560.90 | −8.5% | $513.14 | New | |
| 0.03% | $4.62 | −22.5% | $3.58 | No change | |
| 0.02% | $70.32 | −10.3% | $63.10 | New | |
| 0.02% | $10.63 | −0.7% | $10.56 | New | |
| 0.02% | $6.80 | +31.2% | $8.92 | New | |
Strategy Inc.Bond594972AU5 | 0.01% | — | — | — | New |
| 0.01% | $36.10 | −9.4% | $32.69 | No change | |
| 0.01% | $30.52 | +28.6% | $39.25 | Reduced −89% | |
| 0.01% | $0.33 | +2761% | $9.44 | No change | |
| 0.00% | $6.41 | +369% | $30.08 | No change | |
Aleanna Inc.ANNAW | 0.00% | $0.14 | +78.6% | $0.25 | No change |
Aleanna Inc.ANNA | 0.00% | $0.9536 | +167% | $2.55 | No change |
Welltower Inc.WELL | 0.00% | $186.78 | +19.4% | $223.04 | Reduced −100% |
| 0.00% | $2.29 | — | — | No change | |
Blue Gold Ltd.BGLWW | 0.00% | $0.4682 | −92.0% | $0.0375 | Reduced −15% |
| 0.00% | $10.13 | −77.3% | $2.30 | Reduced −89% | |
Geron Corp.GERN | 0.00% | $3.63 | −66.4% | $1.22 | Reduced −67% |
Nvni Group Ltd-28NVNIW | 0.00% | $0.0355 | −71.3% | $0.0102 | No change |
| 0.00% | $6.45 | −86.9% | $0.847 | Reduced −40% | |
| 0.00% | $1.35 | −41.3% | $0.792 | Reduced −73% | |
Beyond Meat Inc.08862E109 | 0.00% | $3.49 | — | — | No change |
Farallon Capital Management's options
As of Q2 2026. Value = shares the options cover.
| Company | Type | Value of shares covered | Last quarter |
|---|---|---|---|
| Put · bet on a fall or hedge | $4.5B | New | |
| Put · bet on a fall or hedge | $83.3M | New | |
CG Oncology Inc.CGON | Call · bet on a rise | $28.4M | New |
CG Oncology Inc.156944900 | Call · bet on a rise | — | Sold out |
Invesco S&P 500 Equal Weight46137V957 | Put · bet on a fall or hedge | — | Sold out |
SS Spdr S&P 500 ETF Trust-Us78462F953 | Put · bet on a fall or hedge | — | Sold out |
Farallon Capital Management's buys and sells
| Company | Action | Shares change | Value now |
|---|---|---|---|
Hess Corp.HES | Added +116% | +3,455,000 | $981.5M |
| New | +3,500,000 | $480.3M | |
| Sold out | −799,141 | — | |
Airbnb Inc.ABNB | New | +1,608,220 | $265.3M |
Pioneer Natural Resources Co.723787107 | Added +13% | +400,000 | $924M |
| Sold out | −1,697,351 | — | |
| New | +632,000 | $210.9M | |
| Added +41% | +498,810 | $841.7M | |
Splunk Inc.848637104 | Sold out | −1,324,000 | — |
| Added +103% | +1,243,427 | $317.6M | |
| Reduced −34% | −405,715 | $463.5M | |
| Reduced −6.5% | −800,000 | $6B | |
Karuna Therapeutics Inc.48576A100 | Sold out | −522,000 | — |
Astrazeneca Plc-Spons ADR046353108 | Reduced −62% | −2,364,573 | $98.9M |
Nasdaq Inc.NDAQ | Added +28% | +1,866,219 | $532.4M |
Natera Inc.NTRA | Added +13% | +452,800 | $359.2M |
TransunionTRU | Reduced −30% | −2,771,700 | $506.8M |
Mirati Therapeutics Inc.60468T105 | Sold out | −2,024,472 | — |
AramarkARMK | Added +5.5% | +923,683 | $579.6M |
| Reduced −37% | −1,524,200 | $204.7M | |
Ansys Inc.03662Q105 | New | +255,000 | $88.5M |
Vnet Group Inc.Bond90138VAB3 | Sold out | −87,250,000 | — |
| New | +1,349,077 | $85.2M | |
| Reduced −91% | −985,372 | $7.2M | |
| Added +1.4% | +26,430 | $588M | |
Catalent Inc.148806102 | Added +80% | +1,137,000 | $143.9M |
| Reduced −77% | −366,000 | $25.3M | |
| Added +595% | +1,269,900 | $92.3M | |
| Reduced −31% | −11,905,436 | $191.1M | |
| Reduced −88% | −6,437,400 | $9.5M | |
| Added +34% | +1,423,000 | $163.5M | |
Wabtec Corp.WAB | Reduced −25% | −981,910 | $430.7M |
Alphabet Inc.GOOG | Added +6.4% | +199,410 | $508.2M |
Masimo Corp.574795100 | Added +14% | +177,914 | $218.7M |
Icon PLCICLR | New | +179,700 | $60.4M |
Longboard Pharmaceuticals In54300N103 | Added +88% | +1,380,000 | $63.5M |
| Added +4631% | +602,000 | $53.4M | |
S&P Global Inc.SPGI | Reduced −10% | −88,751 | $337.7M |
| Added +247% | +608,949 | $65.8M | |
| Added +11% | +771,018 | $242M | |
| New | +500,000 | $47.4M | |
| Reduced −53% | −821,020 | $31.8M | |
| Reduced −39% | −2,418,918 | $14.1M | |
Cencora Inc.COR | Added +98% | +165,000 | $81.2M |
| Reduced −27% | −228,242 | $134.6M | |
| Added +70% | +262,600 | $67M | |
Humana Inc.HUM | Reduced −57% | −69,644 | $17.9M |
| Reduced −52% | −1,126,578 | $34M | |
| Added +9.9% | +406,000 | $149.1M | |
| Added +0.1% | +4,543 | $166M | |
| Reduced −4.2% | −124,870 | $717.2M | |
Liquidia Corp.LQDA | New | +2,055,000 | $30.3M |
Amedisys Inc.AMED | Added +47% | +322,300 | $92.9M |
Vaxcyte Inc.PCVX | Added +11000% | +374,000 | $25.8M |
| Added +3890% | +1,634,000 | $25.9M | |
Immunogen Inc.45253H101 | Sold out | −842,000 | — |
Geron Corp.GERN | New | +7,495,000 | $24.7M |
Splunk Inc.Bond848637AF1 | Sold out | −23,500,000 | — |
Progyny Inc.PGNY | New | +592,600 | $22.6M |
| Sold out | −55,000 | — | |
| Reduced −17% | −527,000 | $250.6M | |
| Reduced −28% | −1,305,268 | $233.4M | |
| Reduced −21% | −1,223,600 | $314.8M | |
Discover Financial Services254709108 | New | +160,000 | $21M |
Vestis Corp.VSTS | Reduced −10% | −555,000 | $94.7M |
Cerevel Therapeutics Holding15678U128 | Added +87% | +495,679 | $44.9M |
Iqiyi Inc.Bond46267XAE8 | Reduced −13% | −25,000,000 | $161.4M |
Apogee Therapeutics Inc.03770N101 | New | +305,000 | $20.3M |
Elevation Oncology Inc.28623U101 | New | +3,886,663 | $19.9M |
PG&E Corp.PCG | Reduced −44% | −1,000,000 | $21.3M |
Sunrun Inc.Bond86771WAB1 | Added +6.1% | +7,500,000 | $113.3M |
| Added +18% | +1,711,268 | $483.5M | |
| Sold out | −567,800 | — | |
| Reduced −15% | −117,260 | $190M | |
| New | +466,000 | $17.7M | |
| Reduced −39% | −206,000 | $23.8M | |
| New | +1,780,000 | $17.6M | |
| Added +3.5% | +70,000 | $36.6M | |
Savara Inc.SVRA | Reduced −62% | −3,861,107 | $11.9M |
Ventyx Biosciences Inc.92332V107 | New | +3,170,000 | $17.4M |
| Reduced −17% | −106,310 | $247.1M | |
Ascendis Pharma A/S04351P101 | New | +109,000 | $16.5M |
Intra-Cellular Therapies Inc.46116X101 | New | +231,000 | $16M |
Intuit Inc.INTU | Added +0.8% | +4,078 | $349.1M |
Axonics Inc.05465P101 | New | +225,000 | $15.5M |
Avidity Biosciences Inc.05370A108 | New | +606,061 | $15.5M |
Immunome Inc.IMNM | New | +594,000 | $14.7M |
Immunovant Inc.IMVT | Sold out | −341,000 | — |
| New | +1,343,201 | $14.2M | |
Unity Software Inc.Bond91332UAB7 | Sold out | −15,000,000 | — |
| Reduced −0.4% | −17,667 | $65.1M | |
Biohaven Ltd.BHVN | Added +6.5% | +49,000 | $43.7M |
| Reduced −1.5% | −61,970 | $406.9M | |
United States Steel Corp.912909108 | Added +30% | +740,500 | $130.1M |
| Added +77% | +1,000,000 | $21.3M | |
| Sold out | −1,094,000 | — | |
| Sold out | −72,398 | — | |
Sovos Brands Inc.84612U107 | Sold out | −418,000 | — |
| Added +3.3% | +48,890 | $304.2M | |
Bruker Corp.BRKR | Added +2670% | +80,100 | $7.8M |
Snap Inc.Bond83304AAF3 | Sold out | −8,800,000 | — |
Microsoft Corp.MSFT | Reduced −9.5% | −127,120 | $509.7M |
| New | +600,000 | $6.2M | |
Quanterix Corp.QTRX | Added +156% | +287,000 | $11.1M |
Exelixis Inc.EXEL | Added +0.2% | +44,000 | $633.1M |
Soleno Therapeutics Inc.834203309 | Reduced −83% | −137,469 | $1.2M |
Novavax Inc.NVAX | New | +1,131,000 | $5.4M |
| Reduced −95% | −19,900 | $333.5K | |
| New | +750,000 | $5.3M | |
Gores Holdings Ix Inc.38287A101 | Sold out | −500,000 | — |
| New | +710,000 | $4.7M | |
| New | +99,000 | $4.6M | |
Blackline Inc.Bond09239BAD1 | Sold out | −5,000,000 | — |
| Added +1282% | +436,000 | $4.8M | |
Centessa Pharmaceuticals-Adr152309100 | New | +371,000 | $4.2M |
| Reduced −95% | −536,000 | $385.3K | |
Crinetics Pharmaceuticals In22663K107 | Reduced −96% | −117,904 | $234.1K |
Vnet Group Inc.VNET | Reduced −63% | −1,125,000 | $1M |
| Reduced −6.2% | −26,162 | $301.2M | |
| New | +1,150,221 | $3.3M | |
| New | +50,000 | $3.1M | |
| Added +2618% | +445,000 | $3.1M | |
Bluebird Bio Inc.09609G100 | Sold out | −2,000,000 | — |
| New | +151,768 | $2.7M | |
| Reduced −9.4% | −78,262 | $261.8M | |
Zymeworks Inc.ZYME | Reduced −8.8% | −155,000 | $16.8M |
Intuitive Machines Inc.46125A118 | Reduced −54% | −509,035 | $771.7K |
| Sold out | −2,000 | — | |
Biontech Se-AdrBNTX | Sold out | −3,844 | — |
Springworks Therapeutics Inc.85205L107 | New | +5,000 | $246.1K |
| Sold out | −6,000 | — | |
| New | +22,000 | $239.1K | |
Alpine Immune Sciences Inc.02083G100 | New | +5,900 | $233.9K |
| New | +28,000 | $228.8K | |
| New | +2,800 | $228.6K | |
| New | +3,000 | $227.3K | |
| New | +5,000 | $219.4K | |
| Sold out | −3,400 | — | |
| Sold out | −4,600 | — | |
Grifols Sa-AdrGRFS | New | +28,000 | $187K |
Ardelyx Inc.ARDX | New | +23,000 | $167.9K |
| New | +11,000 | $163.6K | |
Beyond Meat Inc.08862E109 | New | +19,000 | $157.3K |
| New | +13,000 | $113.2K | |
Landcadia Holdings IV Inc.51477A112 | Sold out | −125,000 | — |
Social Leverage Acquisn Corp.83363K110 | Sold out | −187,500 | — |
Farallon Capital Management's portfolio by sector
Share of the stock portfolio at Q2 2026.
| Sector | Share |
|---|---|
| Health Care | 62% |
| Technology | 12% |
| Other | 12% |
| Financials | 8.1% |
| Consumer Discretionary | 5.0% |
| Industrials | 1.5% |
| Materials | 0.3% |
| Energy | 0.0% |
| Real Estate | 0.0% |
Portfolio performance: Farallon Capital Management vs. benchmarks
Your result if you had bought each reported portfolio on the day it was made public and held it until the next report, against the S&P 500 and Nasdaq-100.
- You, copying after each 13F filing – estimated value
- S&P 500
- Nasdaq-100
| Total return | Per year | |
|---|---|---|
| You, copying after each 13F filing – estimated value | +56.8% | +9.4% |
| S&P 500 | +89.0% | +13.6% |
| Nasdaq-100 | +113.3% | +16.4% |
Prices were available for 56% of the portfolio value on average; the rest is left out of the return.
Farallon Capital Management's most traded stocks
Quarters with a buy or a sell, all reports since Q2 2013.
| Company | Quarters bought | Quarters sold |
|---|---|---|
Microsoft Corp.MSFT | 25 | 27 |
Alphabet Inc.GOOG | 19 | 24 |
| 19 | 22 | |
Wabtec Corp.WAB | 20 | 18 |
Exelixis Inc.EXEL | 21 | 16 |
TransunionTRU | 15 | 20 |
| 20 | 13 | |
| 18 | 11 | |
Grifols Sa-AdrGRFS | 14 | 14 |
| 15 | 12 | |
| 10 | 17 | |
| 15 | 11 | |
| 16 | 10 | |
| 14 | 12 | |
| 13 | 12 |